 |
Phoenix Neurological Associates, Ltd.
1331 N 7th Street, Suite 350 Phoenix, Arizona 85006 Phone: (602) 258-3354 • Fax: (602) 258-3368 email Phoenix Neurological Associates (If you have an urgent medical issue, do not email; please call us instead.) |
| Clinic Infusion EMG/NCS Muscle Biopsies Research Staff Publications Resources Contact Us Home | ||||
|
Curriculum Vitae for Todd Dylan Levine, M.D.Education1997-1999 Neuromuscle Fellowship 1998-1999 Administrative Chief Resident, Neurology Department 1988-1993 M.D. from Duke University School of Medicine, 1984-1988 B.A. in English Board CertificationAmerican Board of Psychiatry and Neurology, 1998 Employment ExperienceCo-Director, Samaritan Peripheral Neuropathy Center, Director, Samaritan Stroke Clinic Director, Samaritan ALS Clinic Director, Department of Neurophysiology Assistant Professor of Clinical Neurology, Phoenix Neurological Associates, 1999-present Instructor in Clinical Neuromuscular Diseases, 1998-99 Assistant Residency Director, 1998-99 Physician in Internal Medicine, 1994-1998 Emergency Room Physician, 1995-1997 Emergency Room Physician, 1993-1995 AppointmentsMedical Board of Directors, Neuropathy Action Foundation, 2007-present Honors and AwardsNamed as Phoenix Top Doctor, Phoenix Magazine, 2000, 2001, 2003, 2005, 2006, 2007 Professional Society MembershipsFellow of the American Association of Electrodiagnostic Medicine PublicationsLevine T. Rituximab in the treatment of refractory dermatomyositis. Arthritis and Rheumatism Pestronk, A, Levine TD, Florence J, Al-Lozi M, Loapte G, Miller T, Ramneantu I, Waheed W, Stambuk M. Sensory exam with a quantitative tuning fork: Rapid sensitive and predictive of SNAP amplitude. Neurology, Feb 2004; 10;62(3):461-4 Rider L, Giannini E, Brunner H, Ruperto N, Reed A, James-Newton T, Sanghvi M, Cronin M, Garcia-de la Torre I, Isenberg D, Kagen L, Levine T, Lundberg I, Oddis C, Rutkove K, Sivakumar K, Song Y, Targoff J, Vencovsky M, Villalba M, Wortmann R, Ytterberg S, Lachenbruch P, Miller F, For the International Myositis Assessment and Clinical Studies (INACS) Group. Preliminary Definitions of Improvement for Adult Myositis. Arthritis Rheum 2003; 48 (suppl): S307 Gertz MA, Anagnostopoulos A, Anderson K, Branagan A, Frankel S, Giralt S, Levine T. Macroglobulinemia. Seminars in Oncology Vol 30, No 2, April 2003 Levine T, History of dermatomyositis. Arch Neurol May 2003; 60(5): 780-2. Pestronk A, Florence J, Miller T, Choksi R, Al-Lozi M, Levine T, Treatment of IgM-antibody associated neuropathies with rituximab. J Neurol Neurosurg Psychiatry April 2003; 74(4): 485-9 Pestronk A, Choski R, Florence J, Stone M, Levine T, Treon S. Antigenic targets of serum IgM in Waldenstrom’s macroglobulinemia and IgM MGUS. (Manuscript in Preparation, October 2003) Levine TD and Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab. Neurology 52:8; 1701-1705. Levine TD and Pestronk, A. Methotrexate therapy for polymyositis with cytochrome oxidase negative fibers. Muscle and Nerve 21:1724-1728, 1998. Keene, JD, Levine, TD, Gao, FB. US Patent No. 5,525,495, Methods and composition useful in the recognition, binding, and expression of ribonucleic acids involved in cell growth, neoplasia, and immunoregulation. Gao FB, Carson CC, Levine T, and Keene, JD. Selection of a subset of mRNA’s from combinatorial 3’ UTR libraries using neuronal RNA binding protein Hel-N1, PNAS 91(23): 11207, 1994. King PH, Levine TD, Fremeau RT, Keene JD. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3’ UTR of the mRNA encoding the Id transcriptional repressor. Journal of Neuroscience 14(11): 1943, 1994. Levine TD, Gao FB, King PH, Andrews LG, Keene JD. Hel-N1 an autoimmune RNA binding protein with specificity for the 3’ uridylate rich untranslated regions of growth factor mRNAs. Moll. and Cell. Biol. 13 (6): 3494, 1993. PresentationsTreatment of Immune Myopathies. 15th annual Cleveland Review of Rheumatic Diseases, April 2005. B-Cell Depletion Chemotherapy in Neuroimmune Diseases. Barrow’s Neurologic Symposium, March 2005. Peripheral neuropathy in Sjgrens syndrome, American Academy of Neurology April 2004 Treatment of IgM Mediated Neuropathies, 2nd Annual Patient Physician Symposium on Waldenstrom’s Macroglobulinemia, Los Angeles 2003 Treatment of Refractory Dermatomyositis with Rituxamab, American College of Rheumatology, New Orleans, 2002 Antigenic Targets of Serum IgM in Waldenstrom’s Macroglobulinemia and IgM MGUS, 2nd International Workshop on Waldenstrom’s Macroglobulinemia, Athens, Greece 2002. Treatment of IgM Neuropathies, 2nd International Workshop on Waldenstrom’s Macroglobulinemia, Athens, Greece, 2002 Macrophagic Myofasciitis, American Academy of Neurology, April, 2002 Unusual case of acute quadriplegia. American Academy of Neurology, April 2002 B-cell depletion chemotherapy in the treatment of dermatomyositis. 23rd Annual Carrell- Knudsen Symposium, Dallas, Texas, March 2001 Rituxan in the treatment of polyneuropathies. Mayo Clinic, Scottsdale, AZ, December 2000 Clinical ResearchPrincipal Investigator in APPREAVA study of myasthenia gravis Co-Investigator: References:Alan Pestronk, MD David Clifford, MD
|
|||